Supplementary Figure 1. Generation of BRCA2
fl/-and BRCA2 ∆Ex3-4/-cells a. Schematic for generation of BRCA2 fl/-cells by CRISPR-Cas9-mediated gene targeting. Donor fragments for generating the BRCA2 exon 3-4 floxed allele prior to Flp recombination (fl-Hyg) and the null (-) allele are shown. Restriction digestion sites for Southern blotting are indicated. SA-2A, splice acceptor followed by 2A self-cleaving peptide sequence; lightning symbols, CRISPR-Cas9 recognition sites; colored bold lines, probes used for Southern blotting. b-d. Southern blots to confirm targeting of MCF10A cells. The correct bands for the various alleles are indicated by the arrows. Asterisk indicates an unexpected band with the corresponding allele designated with a question mark; this clone was not further interrogated. e. RT-PCR strategy to detect splicing from the ∆Ex3-4 transcript. Using primers that hybridize to BRCA2 exons 1 and 10, a product is detected that contains a portion of intron 2 spliced to intron 4 with several stop codons that are in frame with the normal BRCA2 start codon. The next in-frame ATG codon in exon 7 is indicated. f. Schematic showing domains of BRCA2 protein expressed from + (full-length) and that predicted from the ∆Ex3-4 allele (∆Ex3-4) if translation begins in exon 7. Additional ATGs downstream can also be used to give rise to a similar peptide. g. Western blot of BRCA2 after subcellular protein fractionation, showing that the ∆Ex3-4 peptide is defective in binding to chromatin (NE, soluble nuclear extract; CB, chromatin-bound fraction). The BRCA2 antibody Ab-1 detects BRCA2 amino acids 1651-1821. -/-AAVS1 fl cells The BRCA2 null (-) alleles were generated using the Hygro donor fragment shown in Supplementary Fig.  1a and a cognate donor with a blasticidin-resistance gene replacing the hygromycin-resistance gene. The AAVS1 targeting vector was introduced prior to generating the second BRCA2 null allele. 
Supplementary Figure 3. BRCA2 inactivation causes HR deficiency a. HR analysis. BRCA2
∆Ex3-4/-cells were infected with I-SceI-expressing lentivirus and the percent GFP+ cells was analyzed by an unpaired two-tailed t test. n>3. Error bars, s.d. b. Cisplatin-induced γH2AX. Cells were treated with 5 µM cisplatin for 5 h and released for another 24 h before analysis. γH2AX mean nuclear intensities of >1000 individual cells are shown from one experiment, which is representative of three independent experiments, analyzed by a two-tailed Mann-Whitney test. Box and whiskers show the 10th and 90th percentiles. The dotted red line indicates the median of the BRCA2 mutant cells exposed to cisplatin. c. Olaparib-induced γH2AX. Cells were treated with 5 µM olaparib for 24 h before analysis as in b (representative of two independent experiments). The dotted red line indicates the median of the BRCA2 mutant cells exposed to olaparib. d. IR-induced γH2AX. Cells were irradiated with 5 Gy and harvested 1 or 4 h later. EdU was added to all samples 1h before harvest for analysis. Cell cycle stages were determined based on EdU and DAPI intensity. γH2AX mean nuclear intensities of cells from each cell cycle stage are shown from one experiment, which is representative of two independent experiments, analyzed by a two-tailed Mann-Whitney test. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. **** **** **** ns **** ** **** ns **** **** **** ns Supplementary Fig. 7a ). e. DNA fiber analysis. BRCA2 fl/-p53 -/-and BRCA2 ∆Ex3-4/-p53 -/-cells (derived from pre-and post-Cre colonies from Fig. 3g , respectively) were analyzed for fork protection in the presence of HU, and in the latter case olaparib, as shown in the schematic above. Median CldU/IdU tract length ratios are indicated in the graph (red bars). Graphs represent the pooled results of >300 fibers per sample from three independent experiments, analyzed by a two-tailed Mann-Whitney test. f. Cells were treated without or with olaparib (10 µM, 3 h) prior to Cre expression and then were plated for clonogenic survival, analyzed by an unpaired two-tailed t test. n=3. g. Clonogenic survival analysis using an unpaired two-tailed t test. n=3. Error bars, s.d. ns, not significant; **, p<0.01; ***, p<0.001; ****, p<0.0001. Fig. 4a were also analyzed for γH2AX mean nuclear intensity in cyclin A-and cyclin A+ cells. Median γH2AX intensity, red bars. γH2AX mean nuclear intensities are shown from one experiment, which is representative of two independent experiments, analyzed by a two-tailed MannWhitney test. *, p<0.05; ****, p<0.0001. 
